Dr. Safer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
275 7th Avenue Ste 1505
New York, NY 10001Phone+1 212-604-1790
Summary
- Joshua D. Safer, MD, FACP, FACE is the Executive Director of the Mount Sinai Center for Transgender Medicine and Surgery (CTMS) and Professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Dr. Safer was previously the founding Medical Director of the Center for Transgender Medicine and Surgery at Boston Medical Center and Boston University School of Medicine. Dr. Safer earned his medical degree from the University of Wisconsin. He completed his internal medicine residency at Mount Sinai Beth Israel and his endocrinology fellowship at Beth Israel Deaconess Medical Center in Boston.
Dr. Safer was the inaugural president of the United States Professional Association for Transgender Health (USPATH). He also serves on the Global Education Initiative committee for the World Professional Association for Transgender Health (WPATH) and on the Standards of Care revision committee for WPATH. Dr. Safer was a co-author of the Endocrine Society guidelines for the medical care of transgender patients and has been a scientific co-chair for WPATH's international meetings. In addition, he is a past president of the Association of Specialty Professors, the umbrella organization for leaders in internal medicine subspecialty education, and a former secretary-treasurer of the national endocrinology program director organization, the Association of Program Directors in Endocrinology and Metabolism, (APDEM).
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1993 - 1996
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1990 - 1993
- University of Wisconsin School of Medicine & Public HealthClass of 1990
Certifications & Licensure
- NY State Medical License 1991 - 2025
- MA State Medical License 1993 - 2018
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 1 citationsEvaluating the Risk of Venous Thromboembolism in Transfeminine and Gender Diverse People: A Retrospective Analysis.Daniel J Slack, Nithya Krishnamurthy, Derek Chen, Felix G Contreras-Castro, Joshua D Safer
Endocrine Practice. 2024-11-01 - Further data against the use of cyproterone acetate in gender affirming hormone therapy regimens.Daniel J Slack, Joshua D Safer
The Journal of Clinical Endocrinology and Metabolism. 2024-10-16 - Examining the Influence of the Route of Administration and Dose of Estradiol on Serum Estradiol and Testosterone Levels in Feminizing Gender-Affirming Hormone Therapy.Daniel J Slack, Anaïs Di Via Ioschpe, Michael Saturno, Sky Kihuwa-Mani, Uchechukwu O Amakiri
Endocrine Practice. 2024-10-12
Journal Articles
- Gaps in Transgender Medical Education Among Healthcare Providers: A Major Barrier to Care for Transgender PersonsSira Korpaisarn, Joshua D. Safer, Reviews in Endocrine and Metabolic Disorders
Lectures
- Multidisciplinary Approach to Transgender CareENDO 2019 - New Orleans, LA - 3/25/2019
- Challenging Cases in the Endocrine Management of Gender DysphoriaENDO 2019 - New Orleans, LA - 3/25/2019
- Challenging Cases in the Endocrine Management of Gender Dysphoria (Repeat)ENDO 2019 - New Orleans, LA - 3/25/2019
- Join now to see all
Press Mentions
- Death Threats, Legal Risk and Backlogs Weigh on Clinicians Treating Trans MinorsAugust 28th, 2024
- Trans-Affirming Medical Providers Face Increased Stress & Risk as States Ban Trans Health CareAugust 28th, 2024
- Kansas May Ban Gender-Affirming Care for Minors. Doctors Cite Physical and Mental Costs of WaitingMarch 27th, 2024
- Join now to see all
Grant Support
- Central Resistance To Thyroid HormoneNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
- Central Resistance To Thyroid HormoneNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
Professional Memberships
- Member
- Member
Other Languages
- French, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: